Cocrystal Pharma Q4 EPS $(0.44) Beats $(0.60) Estimate
Cocrystal Pharma, Inc. -4.76% Pre
Cocrystal Pharma, Inc.
COCP
|
1.62
1.62
|
-4.76%
0.00% Pre |
Cocrystal Pharma (NASDAQ:
COCP) reported quarterly losses of $(0.44) per share which beat the analyst consensus estimate of $(0.60) by 26.67 percent. This is a 18.52 percent increase over losses of $(0.54) per share from the same period last year.